- Heir C. et al., How to reduce the risk of VKAs? Use of prescription software. Rev. Prat. Med. Gen., 2007; 21: 42-45.
Hyers YM et al., Chest 2001; 119: 1765-1935.
- Non-valvular atrial fibrillation: What place for non-antivitamin oral anticoagulants K: apixaban (Eliquis®), dabigatran (Pradaxa®) and rivaroxaban (Xarelto®). High Authority of Health. Good use of the drug, July 2013.
- Nacora-Switch study, 2014.